CCL7 and neoplasm: Inflammatory mediators such as IL1β, IL6, and MCP-3 (CCL7) not only drive SCC cell growth but also recruit and condition myeloid populations, including monocytes, tumor-associated macrophages, and MDSCs, thereby promoting a suppressive, tumor-permissive niche (62–66).